Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 156.

Reiner, M F; Stivala, S; Limacher, A; Bonetti, N R; Méan, M; Egloff, M; Rodondi, N; Aujesky, D; von Schacky, C; Lüscher, T F; Camici, G G; Beer, J H (2017). Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism. Journal of Thrombosis and Haemostasis, 15(1):47-56.

Naegele, M; Flammer, A J; Enseleit, F; Roas, S; Frank, M; Hirt, A; Kaiser, P; Cantatore, S; Templin, C; Fröhlich, G; Romanens, M; Lüscher, T F; Ruschitzka, F; Noll, G; Sudano, I (2016). Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome. International Journal of Cardiology, 224:226-230.

Rizzi, G; Startseva, X; Wolfrum, M; Lüscher, T F; Ruschitzka, F; Fröhlich, G M; Enseleit, F (2016). Unfavorable Donor Pretransplant APACHE II, SAPS II, and SOFA Scores Are Not Associated With Outcome: Implications for Heart Transplant Donor Selection. Transplantation Proceedings, 48(8):2582-2587.

Lüscher, T F; Steffel, J (2015). Individualized antithrombotic therapy. Hämostaseologie, 36(1):26-32.

Reiner, M F; Martinod, K; Stivala, S; Savarese, G; Camici, G G; Lüscher, T F; Wagner, D D; Beer, J H (2015). Dietary omega-3 alpha-linolenic acid does not prevent venous thrombosis in mice. Thrombosis and Haemostasis, 113(1):177-184.

Stähli, B E; Gebhard, C; Yonekawa, K; Gebhard, C E; Altwegg, L A; von Eckardstein, A; Hersberger, M; Novopashenny, I; Wolters, R; Wischnewsky, M B; Lüscher, T F; Maier, W (2015). Gender-related differences in patients presenting with suspected acute coronary syndromes: clinical presentation, biomarkers and diagnosis. Cardiology, 132(3):189-198.

Lüscher, T F (2014). Qualität und Integrität bei der Erstellung und Veröffentlichung wissenschaftlicher Ergebnisse. Herz, 39(5):551-557.

Gaehwiler, R; Templin, C; Lüscher, T F; Ghadri, J R (2014). Ein Herz ohne Drehzahlbegrenzung. Praxis, 103(9):527-531.

Wolfrum, M; Starck, C T; Holubec, Tomas; Nietlispach, F; Templin, C; Lüscher, T F (2014). Extrakorporale Membranoxygenierung (ECMO) bei Patienten mit aktuem Koronarsyndrom als Unterstützung bei primärer PCI. Cardiovascular Medicine, 17(5):146-150.

Sudano, I; Pourmand, A; Schoenenberger-Berzins, R; Suter, P M; Roas, S; Templin, C; Landmesser, U; Noll, G; Battegay, E; Erne, P; Lüscher, T F (2014). Klinische Effekte der katheterbasierten Nierennervenablation bei therapieresistenter Hypertonie. Cardiovascular Medicine, 17(1):8-13.

Ghadri, J R; Ruschitzka, F; Lüscher, T F; Templin, C (2014). Prinzmetal angina. QJM : An International Journal of Medicine, 107(5):375-377.

Sarcon, A; Ghadri, J-R; Wong, G; Lüscher, T F; Templin, C; Amsterdam, E (2014). Takotsubo cardiomyopathy associated with opiate withdrawal. QJM : An International Journal of Medicine, 107(4):301-302.

Ghadri, J R; Ruschitzka, F; Lüscher, T F; Templin, C (2014). Takotsubo cardiomyopathy: still much more to learn. Heart, 100(22):1804-1812.

Attinger-Toller, Adrian; Hager, Ph; Rickli, H; Lüscher, T F; Landmesser, U; Nietlispach, F (2014). To do or not to do? Changing paradigms: value of balloon-sizing and left atrial appendage occlusion. Cardiovascular Medicine, 17(1):21-23.

Ghadri, J R; Jaguszewski, M; Sacron, A; Srikantharupan, S; Pfister, P; Siddique, A; Kaufmann, P A; Wyss, C A; Gämperli, O; Landmesser, U; Altwegg, L; Maier, W; Corti, R; Lüscher, T F; Templin, C (2013). Current outcome of acute coronary syndromes: data from the Zurich-Acute Coronary Syndrome (Z-ACS) Registry. Cardiovascular Medicine, 13(4):115-122.

Spescha, R D; Shi, Y; Wegener, S; Keller, S; Weber, B; Wyss, M M; Lauinger, N; Tabatabai, G; Paneni, F; Cosentino, F; Hock, C; Weller, M; Nitsch, R M; Lüscher, T F; Camici, G G (2013). Deletion of the ageing gene p66Shc reduces early stroke size following ischaemia/reperfusion brain injury. European Heart Journal, 34(2):96-103.

Surder, D; Manka, R; Lo Cicero, V; Moccetti, T; et al; Lüscher, T F (2013). Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: Effects on global left ventricular function. Circulation, 127(19):1968-1979.

Manka, R; Busch, J; Crelier, G; Lüscher, T F; Kozerke, S (2013). Pre- and post-operative assessment of valvular and aortic flow using 4D flow magnetic resonance imaging. European Heart Journal, 34(19):1423.

Flammer, A J; Sudano, I; Wolfrum, M; Thomas, R; Enseleit, F; Périat, D; Kaiser, P; Hirt, A; Hermann, M; Serafini, M; Lévêques, A; Lüscher, T F; Ruschitzka, F; Noll, G; Corti, R (2012). Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. European Heart Journal, 33(17):2172-2180.

Moretti, C; Krasniqi, N; Turgut, M; Husmann, M; Roffi, M; Schwarz, U; Greutmann, M; Lüscher, T F; Amann, B; Corti, R (2012). Carotid artery stenting: a single center "real world" experience. PLoS ONE, 7(4):e35300.

Stähli, B E; Bonassin, F; Goetti, R; Küest, S M; Frank, M; Altwegg, L A; Gebhard, C; Levis, A; Wischnewsky, M B; Lüscher, T F; Alkadhi, H; Kaufmann, P A; Maier, W (2012). Coronary computed tomography angiography indicates complexity of percutaneous coronary interventions. Journal of Invasive Cardiology, 24(5):196-201.

Simic, B; Hermann, M; Shaw, S G; Bigler, L; Stalder, U; Dörries, C; Besler, C; Lüscher, T F; Ruschitzka, F (2012). Torcetrapib impairs endothelial function in hypertension. European Heart Journal, 33(13):1615-1624.

Namdar, M; Steffel, J; Jetzer, S; Schmied, C; Hürlimann, D; Camici, G; Bayrak, F; Ricciardi, D; Rao, J Y; de Asmundis, C; Chierchia, G-B; Sarkozy, A; Lüscher, T F; Jenni, R; Duru, F; Brugada, P (2012). Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and fabry disease. American Journal of Cardiology, 109(4):587-593.

Holy, E W; Forestier, M; Richter, E K; Akhmedov, A; Leiber, F; Camici, G G; Mocharla, P; Lüscher, T F; Beer, J H; Tanner, F C (2011). Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(8):1772-1180.

Breitenstein, A; Stein, S; Holy, E W; Camici, G G; Lohmann, C; Akhmedov, A; Spescha, R; Elliott, P J; Westphal, C H; Matter, C M; Lüscher, T F; Tanner, F C (2011). Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells. Cardiovascular Research, 89(2):464-472.

Stähli, B E; Altwegg, L; Lüscher, T F; Corti, R (2011). Acute myocardial infarction after botulinum toxin injection. QJM, 104(7):615-616.

Goetti, R; Kozerke, S; Donati, O F; Sürder, D; Stolzmann, P; Kaufmann, P A; Lüscher, T F; Corti, R; Manka, R (2011). Acute, subacute, and chronic myocardial infarction: quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging. Radiology, 259(3):704-711.

Wolber, T; Haegeli, L; Huerlimann, D; Brunckhorst, C; Lüscher, T F; Duru, F (2011). Altered left ventricular contraction pattern during right ventricular pacing: assessment using real-time three-dimensional echocardiography. Pacing and Clinical Electrophysiology : PACE, 34(1):76-81.

Camici, G G; Shi, Y; Cosentino, F; Francia, P; Lüscher, T F (2011). Anti-aging medicine: molecular basis for endothelial cell-targeted strategies - a mini-review. Gerontology, 57(2):101-108.

Haegeli, L M; Ercin, E; Wolber, T; Brunckhorst, C; Tanner, F C; Jenni, R; Lüscher, T F; Duru, F (2011). Arrhythmic manifestations in patients with congenital left ventricular aneurysms and diverticula. American Journal of Cardiology, 108(12):1826-1830.

Ghadri, J R; Fiechter, M; Templin, C; Lüscher, T F; Kaufmann, P A; Landmesser, Ulf (2011). Cardiac hybrid imaging in a patient with a single coronary artery originating from the right sinus of Valsalva. European Heart Journal, 32(22):2757.

Templin, C; Lüscher, T F; Landmesser, U (2011). Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. International Journal of Developmental Biology, 55(4-5):407-417.

Steffel, J; Milosevic, G; Hürlimann, A; Krasniqi, N; Namdar, M; Ruschitzka, F; Lüscher, T F; Duru, F; Holzmeister, J; Hürlimann, D (2011). Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre. Heart, 97(20):1668-1674.

Haegeli, L M; Greutmann, M; Wolber, T; Appenzeller, P; Gaemperli, O; Brunckhorst, C; Lüscher, T F; Duru, F (2011). Complex cardiac anatomy and catheter access: the role of imaging in patients referred for catheter ablation. Europace, 13(8):1203-1205.

Hermann, M; Enseleit, F; Fisler, A E; Flammer, A; Lüscher, T F; Noll, G; Ruschitzka, F (2011). Cyclosporine C0- versus C2-monitoring over three years in maintenance heart transplantation. Swiss Medical Weekly, 141:w13149.

Rozenberg, I; Sluka, S H M; Mocharla, P; Hallenberg, A; Rotzius, P; Borén, J; Kränkel, N; Landmesser, U; Borsig, L; Lüscher, T F; Eriksson, E E; Tanner, F C (2011). Deletion of L-selectin increases atherosclerosis development in ApoE-/- mice. PLoS ONE, 6(7):e21675.

Winnik, S; Lohmann, C; Richter, E K; Schäfer, N; Song, W L; Leiber, F; Mocharla, P; Hofmann, J; Klingenberg, R; Borén, J; Becher, B; Fitzgerald, G A; Lüscher, T F; Matter, C M; Beer, J H (2011). Dietary {alpha}-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation. European Heart Journal, 32(20):2573-2584.

Winnik, S; Lohmann, C; Richter, E K; Schäfer, N; Song, W L; Leiber, F; Mocharla, P; Hofmann, J; Klingenberg, R; Borén, J; Becher, B; Fitzgerald, G A; Lüscher, T F; Matter, C M; Beer, J H (2011). Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation. European Heart Journal, 32(20):2573-2584.

Hasun, M; Manka, R; Lüscher, T F; Landmesser, U (2011). Dizziness and pre-syncope: an unusual clinical presentation of a spontaneous coronary artery dissection as revealed by optical coherence tomography. Journal of the American College of Cardiology, 58(11):1191.

Namdar, M; Steffel, J; Vidovic, M; Brunckhorst, C B; Holzmeister, J; Lüscher, T F; Jenni, R; Duru, F (2011). Electrocardiographic changes in early recognition of Fabry disease. Heart, 97(6):485-490.

Scharen, E; Paul, M; Lüscher, T F; Corti, R; Manka, R (2011). Evaluation of acute peri-myocarditis with cardiac magnetic resonance imaging. Cardiovascular Medicine, 14(9):266-268.

Templin, C; Ghadri, J R; Rougier, J S; Baumer, A; Kaplan, V; Albesa, M; Sticht, H; Rauch, A; Puleo, C; Hu, D; Barajas-Martinez, H; Antzelevitch, C; Lüscher, T F; Abriel, H; Duru, F (2011). Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). European Heart Journal, 32(9):1077-1088.

Pazhenkottil, A P; Nkoulou, R N; Ghadri, J R; Herzog, B A; Küest, S M; Husmann, L; Wolfrum, M; Goetti, R; Buechel, R R; Gaemperli, O; Lüscher, T F; Kaufmann, P A (2011). Impact of cardiac hybrid single-photon emission computed tomography/computed tomography imaging on choice of treatment strategy in coronary artery disease. European Heart Journal, 32(22):2824-2829.

Steffel, J; Hürlimann, D; Namdar, M; Despotovic, D; Kobza, R; Wolber, T; Holzmeister, J; Haegeli, L; Brunckhorst, C; Lüscher, T F; Jenni, R; Duru, F (2011). Long-term follow-up of patients with isolated left ventricular noncompaction: role of electrocardiography in predicting poor outcome. Circulation Journal, 75(7):1728-34.

Besler, C; Heinrich, K; Rohrer, L; Doerries, C; Riwanto, M; Shih, D M; Chroni, A; Yonekawa, K; Stein, S; Schaefer, N; Mueller, M; Akhmedov, A; Daniil, G; Manes, C; Templin, C; Wyss, C; Maier, W; Tanner, F C; Matter, C M; Corti, R; Furlong, C; Lusis, A J; von Eckardstein, Arnold; Fogelman, A M; Lüscher, T F; Landmesser, U (2011). Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. Journal of Clinical Investigation, 121(7):2693-708.

Yonekawa, K; Neidhart, M; Altwegg, L A; Wyss, C A; Corti, R; Vogl, T; Grigorian, M; Gay, S; Lüscher, T F; Maier, W (2011). Myeloid related proteins activate toll-like receptor 4 in human acute coronary syndromes. Atherosclerosis, 218(2):486-492.

Toggweiler, S; Borst, O; Enseleit, F; Hermann, M; Ruschitzka, F; Lüscher, T F; Noll, G (2011). NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings. Clinical Cardiology, 34(3):183-188.

Sorrentino, S A; Doerries, C; Manes, C; Speer, T; Dessy, C; Lobysheva, I; Mohmand, W; Akbar, R; Bahlmann, F; Besler, C; Schaefer, A; Hilfiker-Kleiner, D; Lüscher, T F; Balligand, J L; Drexler, H; Landmesser, U (2011). Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade. Journal of the American College of Cardiology, 57(5):601-611.

Gebhard, C; Stähli, B E; Shi, Y; Camici, G G; Akhmedov, A; Hoegger, L; Lohmann, C; Matter, C M; Hassa, P O; Hottiger, M O; Malinski, T; Lüscher, T F; Tanner, F C (2011). Poly(ADP-ribose) polymerase-1 protects from oxidative stress induced endothelial dysfunction. Biochemical and Biophysical Research Communications (BBRC), 414(4):641-646.

Blyszczuk, P; Germano, D; Stein, S; Moch, H; Matter, C M; Beck-Schimmer, B; Lüscher, T F; Eriksson, U; Kania, G (2011). Profibrotic potential of Prominin-1+ epithelial progenitor cells in pulmonary fibrosis. Respiratory Research, 12:126.

Jaberg, L; Toggweiler, S; Puck, M; Frank, M; Rufibach, K; Lüscher, T F; Corti, R (2011). Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes undergoing left main percutaneous coronary intervention. Circulation Journal, 75(11):2648-53.

Templin, C; Kränkel, N; Lüscher, T F; Landmesser, U (2011). Stem cells in cardiovascular regeneration: from preservation of endogenous repair to future cardiovascular therapies. Current Pharmaceutical Design, 17(30):3280-3294.

Stähli, B E; Bünzli, R; Grünenfelder, J; Bühler, I; Felix, C; Bettex, D; Biaggi, P; Tanner, F C; Nguyen-Kim, D L; Plass, A; Ge, H; Falk, V; Lüscher, T F; Corti, R; Maier, W; Altwegg, L A (2011). Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the valve academic research consortium (VARC). Journal of Invasive Cardiology, 23(8):307-312.

Stein, S; Lohmann, C; Handschin, C; Stenfeldt, E; Borén, J; Lüscher, T F; Matter, C M (2010). ApoE-/- PGC-1α-/- mice display reduced IL-18 levels and do not develop enhanced atherosclerosis. PLoS ONE, 5(10):e13539.

Hürlimann, D; Steffel, J; Krasniqi, N; Milosevic, G; Gruner, C; Oswald, F; Rahn, M; Falk, V; Noll, G; Lüscher, T F; Ruschitzka, F; Holzmeister, J (2010). Kardiale Resynchronisationstherapie: "Real World"-Erfahrungen eines tertiären Zentrum in der Schweiz. Cardiovascular Medicine, 13(11):334-341.

Holy, E W; Stämpfli, S F; Akhmedov, A; Holm, N; Camici, G G; Lüscher, T F; Tanner, F C (2010). Laminin receptor activation inhibits endothelial tissue factor expression. Journal of Molecular and Cellular Cardiology, 48(6):1138-1145.

Enseleit, F; Kretschmar, O; Lüscher, T F (2010). Percutaneous implantation of an ASD occluder with intracardiac ultrasound. Cardiovascular Medicine, 13(9):290-291.

Gebhard, C; Breitenstein, A; Akhmedov, A; Gebhard, C E; Camici, G G; Lüscher, T F; Tanner, F C (2010). Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4. European Heart Journal, 31(14):1780-1791.

Haegeli, L M; Duru, F; Lockwood, E E; Lüscher, T F; Sterns, L D; Novak, P G; Leather, R A (2010). Ablation of atrial fibrillation after the retirement age: considerations on safety and outcome. Journal of Interventional Cardiac Electrophysiology, 28(3):193-197.

Sudano, I; Flammer, A J; Périat, D; Enseleit, F; Hermann, M; Wolfrum, M; Hirt, A; Kaiser, P; Hurlimann, D; Neidhart, M; Gay, S; Holzmeister, J; Nussberger, J; Mocharla, P; Landmesser, U; Haile, S R; Corti, R; Vanhoutte, P M; Lüscher, T F; Noll, G; Ruschitzka, F (2010). Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation, 122(18):1789-1796.

Stämpfli, S F; Akhmedov, A; Gebhard, C; Lohmann, C; Holy, E W; Rozenberg, I; Spescha, R; Shi, Y; Lüscher, T F; Tanner, F C; Camici, G G (2010). Aging induces endothelial dysfunction while sparing arterial thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(10):1960-1967.

Shi, Y; Camici, G G; Lüscher, T F (2010). Cardiovascular determinants of life span. Pflügers Archiv: European Journal of Physiology (Pflugers Archiv), 459(2):315-324.

Sürder, D; Schwitter, J; Moccetti, T; Astori, G; Rufibach, K; Plein, S; Cicero, V L; Soncin, S; Windecker, S; Moschovitis, A; Wahl, A; Erne, P; Jamshidi, P; Auf der Maur, C; Manka, R; Soldati, G; Bühler, I; Wyss, C; Landmesser, U; Lüscher, T F; Corti, R (2010). Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI). American Heart Journal, 160(1):58-64.

Wyss, C A; Neidhart, M; Altwegg, L; Spanaus, K S; Yonekawa, K; Wischnewsky, M B; Corti, R; Kucher, N; Roffi, M; Eberli, F R; Amann-Vesti, B; Gay, S; von Eckardstein, Arnold; Lüscher, T F; Maier, W (2010). Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. European Heart Journal, 31(12):1457-1469.

Templin, C; Meyer, Martin; Müller, M F; Djonov, V; Hlushchuk, R; Dimova, I; Flueckiger, S; Kronen, P W; Sidler, M; Klein, K; Nicholls, F; Ghadri, J R; Weber, K; Paunovic, D; Corti, R; Hoerstrup, S P; Lüscher, T F; Landmesser, U (2010). Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. European Heart Journal, 31(14):1792-1801.

Asmis, L; Tanner, F C; Sudano, I; Lüscher, T F; Camici, G G (2010). DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents? Biochemical and Biophysical Research Communications (BBRC), 391(4):1629-16333.

Enseleit, F; Lüscher, T F; Ruschitzka, F (2010). Darusentan, a selective endothelin A receptor antagonist, for the oral treatment of resistant hypertension. Therapeutic Advances in Cardiovascular Disease, 4(4):231-240.

Haegeli, L M; Duru, F; Lockwood, E E; Lüscher, T F; Sterns, L D; Novak, P G; Leather, R A (2010). Feasibility and safety of outpatient radiofrequency catheter ablation procedures for atrial fibrillation. Postgraduate Medical Journal, 86(1017):395-398.

Lüscher, T F; Brugada, J; Gersh, B J; Landmesser, U; Serruys, P W; Murphy, S; Dedecke, S; Rogers, S; Ruschitzka, F (2010). Happy birthday European Heart Journal: in 30 years, from Cinderella to centre stage. European Heart Journal, 31(16):1945-1950.

Besler, C; Heinrich, K; Riwanto, M; Lüscher, T F; Landmesser, U (2010). High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease. Current Pharmaceutical Design, 16(13):1480-1493.

Rozenberg, I; Sluka, S H M; Rohrer, L; Hofmann, J; Becher, B; Akhmedov, A; Soliz, J; Mocharla, P; Borén, J; Johansen, P; Steffel, J; Watanabe, T; Lüscher, T F; Tanner, F C (2010). Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(5):923-930.

Giannotti, G; Doerries, C; Mocharla, P S; Mueller, M F; Bahlmann, F H; Horvàth, T; Jiang, H; Sorrentino, S A; Steenken, N; Manes, C; Marzilli, M; Rudolph, K L; Lüscher, T F; Drexler, H; Landmesser, U (2010). Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension, 55(6):1389-1397.

Haegeli, L; Duru, F; Lüscher, T F (2010). Moderne Technologien in der Ablation des Vorhofflimmerns. Kardiovaskuläre Medizin, 13(9):272-280.

Zuchi, C; Ambrosio, G; Lüscher, T F; Landmesser, U (2010). Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function. Cardiovascular Therapeutics, 28(4):187-201.

Wolber, T; On, C J; Brunckhorst, C; Schmied, C; Steffel, J; Lüscher, T F; Duru, F (2010). Patient satisfaction and clinical outcome following outpatient radiofrequency catheter ablation of supraventricular tachycardia. Swiss Medical Weekly, 140(3-4):52-56.

Camici, G G; Steffel, J; Amanovic, I; Breitenstein, A; Baldinger, J; Keller, S; Lüscher, T F; Tanner, F C (2010). Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. European Heart Journal, 31(2):236-242.

Stein, S; Lohmann, C; Schäfer, N; Hofmann, J; Rohrer, L; Besler, C; Rothgiesser, K M; Becher, B; Hottiger, M O; Borén, J; McBurney, M W; Landmesser, U; Lüscher, T F; Matter, C M (2010). SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. European Heart Journal, 31(18):2301-2309.

Stein, S; Schäfer, N; Breitenstein, A; Besler, C; Winnik, S; Lohmann, C; Heinrich, K; Brokopp, C E; Handschin, C; Landmesser, U; Tanner, F C; Lüscher, T F; Matter, C M (2010). SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice. Aging, 2(6):353-360.

Fehr, J S; Bloemberg, G V; Ritter, C; Hombach, M; Lüscher, T F; Weber, R; Keller, P M (2010). Septicemia caused by tick-borne bacterial pathogen Candidatus Neoehrlichia mikurensis. Emerging Infectious Diseases, 16(7):1127-1129.

Templin, C; Ghadri, J R; Wyss, C; Lüscher, T F; Kaufmann, P; Landmesser, U (2010). Severe left main coronary stenosis and mitral regurgitation in a young female patient without cardiovascular risk factors 14 years after mediastinal radiation therapy. Clinical Research in Cardiology, 99(3):199-201.

Binggeli, C; Sudano, I; Corti, R; Spieker, L; Jenni, R; Lüscher, T F; Noll, G (2010). Spontanous periodic breathing is associated with sympathetic hyperreactivity and baroreceptor dysfunction in hypertension. Journal of Hypertension, 28(5):985-992.

Templin, C; Lüscher, T F; Landmesser, U (2010). Stamm- und progenitorzellbasierte Therapieansätze. Aktuelle Entwicklungen zur Behandlung des akuten Myokardinfarkts und der chronischen ischämischen Kardiomyopathie. Herz, 35(7):445-456.

Lüscher, T F; Landmesser, U; Ruschitzka, F (2010). Standing firm - the European Heart Journal, scientific controversies and the industry. European Heart Journal, 31(10):1157-1158.

Breitenstein, A; Tanner, F C; Lüscher, T F (2010). Tissue factor and cardiovascular disease:Quo Vadis? Circulation Journal, 74(1):3-12.

Fröhlich, G; Steffel, J; Hürlimann, D; Enseleit, F; Lüscher, T F; Ruschitzka, F; Abraham, W T; Holzmeister, J (2010). Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling. European Heart Journal, 31(12):1477-1485.

Steffel, J; Lüscher, T F (2010). Zelluläre Hämostase - Endothelzellen. In: Pötzsch, B; Madlener, K. Hämostaseologie : Grundlagen, Diagnostik und Therapie. Heidelberg: Springer, 97-104.

Lohmann, C; Schäfer, N; von Lukowicz, T; Sokrates Stein, M A S; Borén, J; Rütti, S; Wahli, W; Donath, M Y; Lüscher, T F; Matter, C M (2009). Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets. Atherosclerosis, 207(2):360-367.

Gebhard, C; Akhmedov, A; Mocharla, P; Angstenberger, J; Sahbai, S; Camici, G G; Lüscher, T F; Tanner, F C (2009). PDGF-CC induces tissue factor expression: role of PDGF receptor alpha/beta. Basic Research in Cardiology, 105(3):349-356.

Steffel, J; Kobza, R; Namdar, M; Wolber, T; Brunckhorst, C; Lüscher, T F; Jenni, R; Duru, F (2009). Electrophysiological findings in patients with isolated left ventricular non-compaction. Europace, 11(9):1193-1200.

Namdar, M; Schepis, T; Koepfli, P; Gaemperli, O; Siegrist, P T; Grathwohl, R; Valenta, I; Delaloye, R; Klainguti, M; Wyss, C A; Lüscher, T F; Kaufmann, P A (2009). Caffeine impairs myocardial blood flow response to physical exercise in patients with coronary artery disease as well as in age-matched controls. PLoS ONE, 4(5):e5665.

Germano, D; Blyszczuk, P; Valaperti, A; Kania, G; Dirnhofer, S; Landmesser, U; Lüscher, T F; Hunziker, L; Zulewski, H; Eriksson, U (2009). Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 179(10):939-949.

Gerlich, M G; Krämer, A; Gmel, Gerhard; Maggiorini, M; Lüscher, T F; Rickli, H; Kleger, G R; Rehm, Jürgen (2009). Patterns of alcohol consumption and acute myocardial infarction: a case-crossover analysis. European Addiction Research, 15(3):143-149.

Steffel, J; Lüscher, T F (2009). Gerinnungshemmung im akuten Koronarsyndrom. Therapeutische Umschau, 66(4):301-308.

Becker, M C; Wang, T H; Wisniewski, L; Wolski, K; Libby, P; Lüscher, T F; Borer, J S; Mascette, A M; Husni, M E; Solomon, D H; Graham, D Y; Yeomans, N D; Krum, H; Ruschitzka, F; Lincoff, A M; Nissen, S E (2009). Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. American Heart Journal, 157(4):606-612.

Flammer, A J; Vo, N T T; Ledergerber, B; Hermann, F; Gämperli, A; Huttner, A; Evison, J; Baumgartner, I; Cavassini, M; Hayoz, D; Quitzau, K; Hersberger, M; Sudano, I; Ruschitzka, F; Lüscher, T F; Noll, G; Weber, R (2009). Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomized controlled trial. Heart, 95(5):385-390.

Camici, G G; Sudano, I; Noll, G; Tanner, F C; Lüscher, T F (2009). Molecular pathways of aging and hypertension. Current Opinion in Nephrology and Hypertension, 18(2):134-137.

Burkhardt, T; Matter, C M; Lohmann, C; Cai, H; Lüscher, T F; Zisch, A H; Beinder, E (2009). Decreased umbilical artery compliance and igf-I plasma levels in infants with intrauterine growth restriction - implications for fetal programming of hypertension. Placenta, 30(2):136-141.

Lüscher, T F; Gersch, B; Brugada, J; Landmesser, U; Ruschitzka, F; Serruys, P W (2009). The European Heart Journal goes global: the road ahead of the editorial team 2009-2011. European Heart Journal, 30(1):1-5.

Amstein, R; Enseleit, F; Lüscher, T F (2009). 5. «Cardiovascular Roundtable». Schweizerische Ärztezeitung, 90(9):329.

Steffel, J; Lüscher, T F (2009). Antikoagulation betagter Patienten - Der schmale Grat zwischen Nutzen und Risiko. MMW-Fortschritte der Medizin, 151(16):33-36.

Corti, R; Flammer, A J; Hollenberg, N K; Lüscher, T F (2009). Cocoa and cardiovascular health. Circulation, 119(10):1433-1441.

Distler, J H W; Beyer, C; Schett, G; Lüscher, T F; Gay, S; Distler, O (2009). Endothelial progenitor cells: Novel players in the pathogenesis of rheumatic diseases. Arthritis and Rheumatism, 60(11):3168-3179.

Anker, S D; Comin Colet, J; Filippatos, G; Willenheimer, R; Dickstein, K; Drexler, H; Lüscher, T F; Bart, B; Banasiak, W; Niegowska, J; Kirwan, B A; Mori, C; von Eisenhart Rothe, B; Pocock, S J; Poole-Wilson, P A; Ponikowski, P (2009). Ferric carboxymaltose in patients with heart failure and iron deficiency. New England Journal of Medicine, 361(25):2436-2448.

Frei, P; Huber, L C; Simon, R W; Bonani, M; Lüscher, T F (2009). Insufficient medication documentation at hospital admission of cardiac patients: a challenge for medication reconciliation. Journal of Cardiovascular Pharmacology, 54(6):497-501.

Blyszczuk, P; Kania, G; Dieterle, T; Marty, R R; Valaperti, A; Berthonneche, C; Pedrazzini, T; Berger, C T; Dirnhofer, S; Matter, C M; Penninger, J M; Lüscher, T F; Eriksson, U (2009). Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circulation Research, 105(9):912-920.

Steffel, J; Lüscher, T F (2009). Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors. Journal of Cardiovascular Medicine, 10(8):616-623.

Steffel, J; Lüscher, T F (2009). Predicting the development of atherosclerosis. Circulation, 119(7):919-921.

The ESC Textbook of Cardiovascular Medicine (2nd edition). Edited by: Camm, J A; Lüscher, T F; Serruys, P W (2009). Oxford: Oxford University Press.

Breitenstein, A; Stämpfli, S F; Camici, G G; Akhmedov, H R; Ha, H R; Follath, F; Bogdanova, A; Lüscher, T F; Tanner, F C (2008). Amiodarone inhibits arterial thrombus formation and tissue factor translation. Arteriosclerosis Thrombosis and Vascular Biology, 28(12):2231-2238.

Camici, G G; Cosentino, C; Tanner, F C; Lüscher, T F (2008). The role of p66Shc deletion in age-associated arterial dysfunction and disease states. Journal of Applied Physiology, 105(5):1628-1631.

Osto, E; Kuroedov, A; Mocharla, P; Akhmedov, A; Besler, C; Rohrer, L; von Eckardstein, A; Iliceto, S; Volpe, M; Lüscher, T F; Cosentino, F (2008). Inhibition of protein kinase Cbeta prevents foam cell formation by reducing scavenger receptor A expression in human macrophages. Circulation, 118(21):2174-2182.

Osto, E; Matter, C M; Kouroedov, A; Malinski, T; Bachschmid, M; Camici, G G; Kilic, U; Stallmach, T; Boren, J; Iliceto, S; Lüscher, T F; Cosentino, F (2008). c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress. Circulation, 118(20):2073-2080.

Largiadèr, T; Masato, E; Payeli, S K; Greutert, H; Viswambharan, H; Lachat, Mario L; Zünd, G; Yang, Z; Tanner, F C; Lüscher, T F (2008). Endothelial nitric oxide synthase gene transfer inhibits human smooth muscle cell migration via inhibition of Rho A. Journal of Cardiovascular Pharmacology, 52(4):369-374.

Delli Gatti, C; Osto, E; Kouroedov, A; Eto, M; Shaw, S; Volpe, M; Lüscher, T F; Cosentino, F (2008). Pulsatile stretch induces release of angiotensin II and oxidative stress in human endothelial cells: effects of ACE inhibition and AT1 receptor antagonism. Clinical and Experimental Hypertension, 30(7):616-627.

Enseleit, F; Lüscher, T F; Ruschitzka, F (2008). Darusentan: a new perspective for treatment of resistant hypertension? Expert Opinion on Investigational Drugs, 17(8):1255-1263.

Roffi, M; Greutmann, M; Eberli, F R; Rainoni, L; Lüscher, T F; Amann-Vesti, B; Schwarz, U (2008). Starting a carotid artery stenting program is safe. Catheterization and Cardiovascular Interventions, 71(4):469-473.

Payeli, S K; Latini, R; Gebhard, K; Patrignani, A; Wagner, U; Lüscher, T F; Tanner, F C (2008). Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery. Arteriosclerosis, Thrombosis and Vascular Biology, 28(4):705-710.

Cosentino, F; Hürlimann, D; Delli Gatti, C; Chenevard, R; Blau, N; Alp, N J; Channon, K M; Eto, M; Lerch, P; Enseleit, F; Ruschitzka, F; Volpe, M; Lüscher, T F; Noll, G (2008). Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart, 94(4):487-492.

Payeli, S K; Schiene-Fischer, C; Steffel, J; Camic, G G; Rozenberg, I; Lüscher, T F; Tanner, F C (2008). Cyclophilin A differentially activates monocytes and endothelial cells Role of purity, activity, and endotoxin contamination in commercial preparations. Atherosclerosis, 197(2):564-571.

Cosentino, F; Francia, P; Camici, G G; Pelicci, P G; Lüscher, T F; Volpe, M (2008). Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. Arteriosclerosis Thrombosis and Vascular Biology, 28(4):622-628.

von Lukowicz, T; Hassa, P O; Lohmann, C; Borén, J; Braunersreuther, V; Mach, F; Odermatt, B; Gersbach, M; Camici, G G; Stähli, B E; Tanner, F C; Hottiger, Michael O; Lüscher, T F; Matter, C M (2008). PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovascular Research, 78(1):158-166.

Stähli, B E; Breitenstein, A; Akhmedov, A; Camici, G G; Shojaati, K; Bogdanov, N; Steffel, J; Ringli, D; Lüscher, T F; Tanner, F C (2007). Cardiac glycosides regulate endothelial tissue factor expression in culture. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(12):2769-2776.

Tanner, F C; van der Loo, B; Shaw, S; Greutert, H; Bachschmid, M M; Berrozpe, M; Rozenberg, I; Blau, N; Siebenmann, R; Schmidli, J; Meyer, P; Lüscher, T F (2007). Inactivity of nitric oxide synthase gene in the atherosclerotic human carotid artery. Basic Research in Cardiology, 102(4):308-317.

Schepis, T; Koepfli, P; Leschka, S; Desbiolles, L; Husmann, L; Gaemperli, O; Eberli, F R; Wildermuth, S; Marincek, B; Lüscher, T F; Alkadhi, H; Kaufmann, P A (2007). Coronary artery stent geometry and in-stent contrast attenuation with 64-slice computed tomography. European Radiology, 17(6):1464-1473.

Lüscher, T F; Steffel, J; Eberli, F R; Joner, M; Nakazawa, G; Tanner, F C; Virmani, R (2007). Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation, 115(8):1051-1058.

Béchir, M; Schwegler, K; Chenevard, R; Binggeli, C; Caduff, C; Büchi, S; Buddeberg, C; Lüscher, T F; Noll, G (2007). Anxiolytic therapy with alprazolam increases muscle sympathetic activity in patients with panic disorders. Autonomic Neuroscience, 134(1-2):69-73.

Sudano, I; Virdis, A; Taddei, S; Spieker, I; Corti, R; Noll, G; Salvetti, A; Lüscher, T F (2007). Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension. Hypertension, 49(2):285-290.

Camici, G G; Stallmach, T; Hermann, M; Hassink, R; Doevendans, P; Grenacher, B; Hirschy, A; Vogel, J; Lüscher, T F; Ruschitzka, F; Gassmann, M (2007). Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. Methods in Enzymology, 435:147-155.

Flammer, A J; Hermann, F; Sudano, I; Spieker, L; et al; Lüscher, T F; Ruschitzka, F; Noll, G; Corti, R (2007). Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation, 116(21):2376-2382.

Flammer, A J; Hermann, F; Wiesli, P; Schwegler, B; Chenevard, R; Hurlimann, D; Sudano, I; Gay, S; Neidhart, M; Riesen, W; Ruschitzka, F; Lüscher, T F; Noll, G; Lehmann, R (2007). Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. Journal of Hypertension, 25(4):785-791.

von Lukowicz, T; Silacci, M; Wyss, M T; Trachsel, E; Lohmann, C; Buck, A; Lüscher, T F; Neri, D; Matter, C M (2007). Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivo. Journal of Nuclear Medicine, 48(4):582-587.

Steffel, J; Lüscher, T F; Tanner, F C (2006). Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation, 113(5):722-731.

Sudano, I; Spieker, L E; Noll, G; Corti, R; Weber, R; Lüscher, T F (2006). Cardiovascular disease in HIV infection. American Heart Journal, 151(6):1147-1155.

Hermann, F; Spieker, L E; Ruschitzka, F; Sudano, I; Hermann, M; Binggeli, C; Lüscher, T F; Riesen, W; Noll, G; Corti, R (2006). Dark chocolate improves endothelial and platelet function. Heart, 92(1):119-120.

Kurz, D J; Kloeckener-Gruissem, B; Akhmedov, A; Eberli, F R; Bühler, I; Berger, W; Bertel, O; Lüscher, T F (2006). Degenerative aortic valve stenosis, but not coronary disease, is associated with shorter telomere length in the elderly. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(6):e114-e117.

Chenevard, R; Béchir, M; Hürlimann, D; Ruschitzka, F; Turina, J; Lüscher, T F; Noll, G (2006). Persistent endothelial dysfunction in calcified aortic stenosis beyond valve replacement surgery. Heart, 92(12):1862-1863.

Steffel, J; Hermann, M; Greutert, H; Gay, S; Lüscher, T F; Ruschitzka, F; Tanner, F C (2005). Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation, 111(13):1685-1689.

Sudano, I; Spieker, L; Binggeli, C; Ruschitzka, F; Lüscher, T F; Noll, G; Corti, R (2005). Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkers. Hypertension, 46(3):521-526.

Szucs, T D; Schwenkglenks, M; Lüscher, T F; Eberli, F (2005). Die Wirtschaftlichkeit beschichteter Stents in der interventionellen Kardiologie - eine gesamtschweizerische Analyse. Kardiovaskuläre Medizin, 8:41-52.

Béchir, M; Enseleit, F; Chenevard, R; Lüscher, T F; Noll, G (2005). Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertension. American Journal of Cardiology, 95(1):129-131.

Noll, G; et al; Lüscher, T F (2005). Endogenous estrogens increase postischemic hyperemia in the skin microcirculation. Journal of Cardiovascular Pharmacology, 45(5):414-417.

Bechir, M; Enseleit, F; Chenevard, R; Muntwyler, J; Lüscher, T F; Noll, G (2005). Folic Acid improves baroreceptor sensitivity in hypertension. Journal of Cardiovascular Pharmacology, 45(1):44-48.

Hermann, M; Shaw, S; Kiss, E; Camici, G; Buhler, N; Chenevard, R; Lüscher, T F; Gröne, H J; Ruschitzka, F (2005). Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hypertension, 45(2):193-197.

Spieker, L E; Ruschitzka, F; Lüscher, T F; Noll, G (2004). HDL and inflammation in atherosclerosis. Current Drug Targets. Immune, Endocrine & Metabolic Disorders, 4(1):51-57.

Anand, I; McMurray, J; Cohn, J N; Konstam, M A; Notter, T; Quitzau, K; Ruschitzka, F; Lüscher, T F (2004). Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet, 364(9431):347-354.

Karadag, B; Spieker, L E; Schwitter, J; Ruschitzka, F; Lüscher, T F; Noll, G; Corti, R (2004). Lyme carditis: restitutio ad integrum documented by cardiac magnetic resonance imaging. Cardiology in Review, 12(4):185-187.

Ruschitzka, F; et al; Noll, G; Lüscher, T F; Hänseler, E (2003). Detection of a novel exon 4 low-density lipoprotein receptor gene deletion in a swiss family with severe familial hypercholesterolemia. Clinical Chemistry and Laboratory Medicine, 41(3):266-271.

Hermann, M; et al; Lüscher, T F; Ruschitzka, F (2003). Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension. Circulation, 108(19):2308-2311.

Béchir, M; Binggeli, C; Corti, R; Chenevard, R; Spieker, L; Ruschitzka, F; Lüscher, T F; Noll, G (2003). Dysfunctional baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope. Circulation, 107(12):1620-1625.

Spieker, L E; Lüscher, T F; Noll, G (2003). ETA receptors mediate vasoconstriction of large conduit arteries during reduced flow in humans. Journal of Cardiovascular Pharmacology, 42(3):315-318.

Ruschitzka, F; et al; Lüscher, T F; Gassmann, M (2003). Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice. FASEB Journal, 17(2):259-261.

Bürgi Wegmann, B; Sütsch, G; Rickli, H; Seifert, Burkhardt; Muntwyler, J; Lüscher, T F; Kiowski, W; Attenhofer Jost, C H (2003). Gender and noninvasive diagnosis of coronary artery disease in women and men. Journal of women's health, 12(1):51-59.

Chenevard, R; et al; Lüscher, T F; Noll, G; Ruschitzka, F (2003). Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation, 107(3):405-409.

Binggeli, C; Spieker, L E; Corti, R; Sudano, I; Stojanovic, V; Hayoz, D; Lüscher, T F; Noll, G (2003). Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? Journal of the American College of Cardiology, 42(1):71-77.

Ruschitzka, F T; Wenger, R H; Stallmach, T; Quaschning, T; de Wit, C; Wagner, K; Labugger, R; Kelm, M; Noll, G; Rülicke, T; Shaw, S; Lindberg, R L; Rodenwaldt, B; Lutz, H; Bauer, C; Lüscher, T F; Gassmann, M (2000). Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 97(21):11609-11613.

Szucs, Thomas D; Lüscher, T F; Gutzwiller, Felix (1997). Einfluss der medikamentösen Cholesterinsenkung auf den Ressourcenverbrauch im Gesundheitswesen - Bedeutung der Scandinavian Simvastatin Survival Study (4-S-Studie) für die Kostenreduktion unter Schweizer Verhältnissen. Swiss Medical Weekly, 127(44):1819-1823.

This list was generated on Tue Aug 14 10:05:46 2018 CEST.